A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
批准号:
10729147
负责人:
Susan C Pitt
金额:
$8.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2025-07-31
关键词:
AddressAgeAmericanAwardAwarenessBehaviorBehavior TherapyCancer SurvivorCaregiversClinicClinic VisitsClinicalClinical TrialsCollaborationsCommunicationCommunitiesConsultDataData CollectionDecision MakingDeimplementationDiagnosisExpectancyFatigueFeasibility StudiesFutureGoalsHealthHealth systemIndividualInterventionIntervention StudiesInterviewKnowledgeLanguageLongevityMalignant NeoplasmsMalignant neoplasm of thyroidMeasuresMethodologyMissionMorbidity - disease rateOperative Surgical ProceduresOutcomePapillary thyroid carcinomaParticipantPatient PreferencesPatientsPilot ProjectsPositioning AttributeProceduresProcessProtocols documentationProviderQualifyingQuality of lifeRandomizedRandomized, Controlled TrialsReadinessRecommendationRecording of previous eventsRecurrenceResearchRiskSelf EfficacySideSiteStructureSurgeonSurvivorsTestingThyroid GlandThyroidectomyTimeVisitVocal Cord ParalysisWorkacceptability and feasibilitycancer carecare costscohortcostdisabilityevidence baseexperienceimprovedinnovationintervention effectmultidisciplinarynovelovertreatmentpragmatic efficacy trialprimary outcomepsychosocialrecruitsecondary outcomeshared decision makingsocial cognitive theorytherapy designtreatment as usualtreatment choicetreatment riskultrasounduptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Nearly 90% of patients with low-risk papillary thyroid cancer undergo total thyroidectomy, the treatment option
with the greatest morbidity, even though less invasive options offer equivalent recurrence and survival.
Overtreatment of these patients results in significant patient harm and substantial costs. Currently, patients
have unmet informational needs that contribute to the uptake of total thyroidectomy. Patients with low-risk
papillary thyroid cancer would benefit from an intervention that meets their informational needs and increases
their ability to participate in the decision-making process. This proposal is a key step to support our longer-term
goal of reducing overtreatment of low-risk thyroid cancer by intervening on surgical decision making.
Our research team developed a novel intervention called CQUPLE, which includes (1) a Chart of side-by-side,
evidence-based information comparing all three management options for low-risk thyroid cancer, including
expected outcomes and (2) a Question Prompt List that contains key questions to consider asking the
surgeon. The intervention is grounded in social cognitive theory and aims to increase patient awareness of
treatment options and their outcomes, patient activation, and self-efficacy for decision making. This proposal
will pilot CQUPLE at three clinic sites in a single health system. We propose a pilot feasibility randomized
controlled trial in 50 patients with low-risk papillary thyroid cancer to evaluate the feasibility and acceptability of
CQUPLE (Aim 1) and characterize the distribution of outcomes (Aim 2).
The results of the proposed research will provide the preliminary data necessary to prepare for a future, large-
scale pragmatic efficacy trial to test the effect of CQUPLE on patients’ choice for total thyroidectomy. CQUPLE
is a low-cost, scalable, patient-directed intervention that is innovative because it combines two complimentary
components that work to meet patients’ informational and decisional needs through different mechanisms. The
research is significant because reducing rates of total thyroidectomy for patients with low-risk thyroid cancer
has the potential to decrease patient harm and improve long-term outcomes. Our multidisciplinary team’s
history of successful collaboration and experience in behavioral intervention design and testing with
randomizes controlled trials make us well positioned to achieve the aims of this award.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer
-
批准号:10790089
-
项目类别:
-
资助金额:$14.24万
-
财政年份:2018
-
负责人:Susan C Pitt
-
依托单位:
Impact of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer
-
批准号:10443661
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2018
-
负责人:Susan C Pitt
-
依托单位:
Impact of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer
-
批准号:10206057
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2018
-
负责人:Susan C Pitt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: